An investigation into the prescribing patterns of selective serotonin re-uptake inhibitors in South Africa

Journal of Clinical Pharmacy and Therapeutics

Volumn 21, Issue 4, 1996, Pages 237-242

  Truter, I ^a   Kotze, T J Van W ^b  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGE; ARTICLE; DEPRESSION; DRUG USE; HUMAN; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; SEX DIFFERENCE; SOUTH AFRICA;

EID: 0029809945     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2710.1996.tb01144.x     Document Type: Article

References (12)

1. Bingefors KAL, Isacson DGL, Von Knorring L, Smedby B. (1995) Prescription drug and Healthcare use among Swedish patients treated with antidepressants. The Annals of Pharmacotherapy, 29, 566-572.
2. Anon. (1995) The selective serotonin re-uptake inhibitors - a review and new uses. Medifile Drug Information Bulletin. TPS Drug Information Centre, Johannesburg, South Africa, 9, 65-68.
3. Serradell J, Bjornson DC, Hartzema AG. (1987) Drug utilization study methodologies: national and international perspectives. Drug Intelligence and Clinical Pharmacy, 21, 994-1001.
4. Wertheimer AI. (1986) The defined daily dose system (DDD) for drug utilization review. Hospital Pharmacy, 21, 233-258.
5. Szuba TJ, Westerholm B. (1989) Studies on drug utilization: bilateral case study in Poland and Sweden. Social Science and Medicine, 29, 1363-1366.
6. Capellà D. (1993) Descriptive tools and analysis. In: Drug Utilization Studies: Methods and Uses, ed. Dukes MNG. WHO Regional Publications, European Series, no. 45, pp. 55-78.
7. WHO Drug Utilization Research Group. (1985) Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden. European Journal of Clinical Pharmacology, 29, 1-8.
8. Hemminki E. (1982) Problems in the measurement of psychotropic drug consumption. American Journal of Hospital Pharmacy, 39, 325-329.
9. Tansella M, Micciolo R. (1992) Trends in the prescription of antidepressants in urban and rural general practices. Journal of Affective Disorders, 24, 117-125.
10. Anon. (1995) Selecting an antidepressant. MeReC Bulletin. Medicines Resource Centre, Liverpool, U.K., 6, 1-4.
11. Van Rooyen RJ, Snyman JR eds. (1995) MIMS Medical Specialities. Times Media Limited, Pretoria, South Africa, 35(8), 7-14.
12. WHO. (1995) Anatomical Therapeutic Chemical (ATC) classification index including defined daily doses (DDDs) for plain substances. WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway.